Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins - Significance for the patient
- Author(s)
- Christian Hartinger, Stephan Hann, Gunda Köllensperger, Michael Sulyok, Michael Größl, Andrei Timerbaev, Alexander V. Rudnev, Gerhard Stingeder, Bernhard Keppler
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- University of Natural Resources and Life Sciences, Russian Academy of Sciences
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Volume
- 43
- Pages
- 583-585
- No. of pages
- 3
- ISSN
- 0946-1965
- Publication date
- 2005
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 104003 Inorganic chemistry, 301904 Cancer research
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/2dea8d93-732c-4379-89ea-aea7138f19bc